We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
-3.09%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.47B
AUM Growth
-$81M
Cap. Flow
-$152K
Cap. Flow %
-0.01%
Top 10 Hldgs %
30.16%
Holding
216
New
9
Increased
67
Reduced
76
Closed
10

Top Buys

Rank Stock Value
1
SHEL icon
Shell
SHEL
+$12.1M
2
PPLI
People Inc
PPLI
+$3.64M
3
AZO icon
AutoZone
AZO
+$2.79M
4
IWB icon
iShares Russell 1000 ETF
IWB
+$1.09M
5
DIS icon
Walt Disney
DIS
+$860K

Top Sells

Rank Stock Value
1
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$9.51M
2
BC icon
Brunswick
BC
+$3.76M
3
FDX icon
FedEx
FDX
+$3.74M
4
MSFT icon
Microsoft
MSFT
+$1.88M
5
DVN icon
Devon Energy
DVN
+$864K

Sector Composition

Rank Sector Weight
1 Technology 29.23%
2 Healthcare 15.02%
3 Industrials 12.32%
4 Financials 11.75%
5 Consumer Staples 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGEN
76
DELISTED
Seagen Inc. Common Stock
SGEN
$2.12M 0.14%
14,709
+269
+2% +$36.4K
EBAY icon
77
eBay
EBAY
$52.1B
$2.09M 0.14%
36,530
-8,830
-19% -$514K
SPY icon
78
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$2.01M 0.14%
4,444
+139
+3% +$61.9K
AMZN icon
79
Amazon
AMZN
$2.48T
$1.98M 0.13%
12,120
-20
-0.2% -$3.09K
ABT icon
80
Abbott
ABT
$187B
$1.81M 0.12%
15,311
-300
-2% -$37.2K
TJX icon
81
TJX Companies
TJX
$178B
$1.77M 0.12%
29,187
HON icon
82
Honeywell
HON
$78.3B
$1.72M 0.12%
9,359
-318
-3% -$58.9K
CL icon
83
Colgate-Palmolive
CL
$74.2B
$1.71M 0.12%
22,491
-674
-3% -$53.4K
FAST icon
84
Fastenal
FAST
$55.2B
$1.69M 0.11%
56,892
MMM icon
85
3M
MMM
$94.1B
$1.69M 0.11%
13,572
-204
-1% -$27.1K
HD icon
86
Home Depot
HD
$343B
$1.63M 0.11%
5,456
ADP icon
87
Automatic Data Processing
ADP
$106B
$1.59M 0.11%
6,981
+338
+5% +$72.4K
UNP icon
88
Union Pacific
UNP
$175B
$1.44M 0.1%
5,257
CTRA
89
DELISTED
Coterra Energy
CTRA
$1.35M 0.09%
50,104
IVV icon
90
iShares Core S&P 500 ETF
IVV
$871B
$1.35M 0.09%
2,985
+53
+2% +$23.7K
BMY icon
91
Bristol-Myers Squibb
BMY
$130B
$1.32M 0.09%
18,139
-753
-4% -$50.6K
EMR icon
92
Emerson Electric
EMR
$85B
$1.3M 0.09%
13,264
-56
-0.4% -$5.3K
ISRG icon
93
Intuitive Surgical
ISRG
$130B
$1.3M 0.09%
4,311
NBIX icon
94
Neurocrine Biosciences
NBIX
$18.4B
$1.29M 0.09%
13,797
+566
+4% +$48K
VV icon
95
Vanguard Large-Cap ETF
VV
$52B
$1.28M 0.09%
6,158
+834
+16% +$171K
INCY icon
96
Incyte
INCY
$26B
$1.22M 0.08%
15,380
+470
+3% +$34.2K
TSLA icon
97
Tesla
TSLA
$1.21T
$1.22M 0.08%
3,384
-1,299
-28% -$405K
IWB icon
98
iShares Russell 1000 ETF
IWB
$47.9B
$1.1M 0.07%
+4,397
New +$1.09M
BMRN icon
99
BioMarin Pharmaceuticals
BMRN
$12B
$1.07M 0.07%
13,926
+456
+3% +$38.2K
IONS icon
100
Ionis Pharmaceuticals
IONS
$9.14B
$1.04M 0.07%
28,001
+1,230
+5% +$40.3K

Similar funds

Grandfield & Dodd's Q1 2022 Portfolio in Review

As of Q1 2022, Grandfield & Dodd held 216 positions worth $1.47B, down 5.2% from $1.55B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Grandfield & Dodd's Q1 2022 filing shows 9 new, 67 increased, 76 reduced and 10 closed positions. Its largest new stake was Shell: 227,559 shares worth $12.5M. The largest sale was Royal Dutch Shell PLC ADS Class B, an estimated $9.51M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q1 2022 buy was Shell: 227,559 shares worth $12.5M.
  • Grandfield & Dodd added most to People Inc in Q1 2022, an estimated $3.64M increase.
  • Grandfield & Dodd's biggest Q1 2022 reduction was Brunswick, cutting an estimated $3.76M.
  • Grandfield & Dodd fully exited Royal Dutch Shell PLC ADS Class B in Q1 2022, selling an estimated $9.51M.
  • Grandfield & Dodd's ten largest holdings make up 30% of its $1.47B portfolio in Q1 2022.
  • Grandfield & Dodd opened 9 new positions and closed 10 in Q1 2022.
  • Grandfield & Dodd's portfolio value fell 5.2% quarter-over-quarter to $1.47B.

Based on Grandfield & Dodd's 13F filing for Q1 2022, filed 19 Apr 2022.